Clinical Trials Logo

Wound Contamination clinical trials

View clinical trials related to Wound Contamination.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04507724 Completed - Wound Infection Clinical Trials

The Use of Biochemical Analyzes to Monitor the Development of Wounds

NPWW
Start date: October 19, 2018
Phase:
Study type: Observational

Chronic wounds represent a growing challenge in medical care. Part 1: The aim of this part of the study was to collect wound swabs and to answer the question whether the rapid diagnostic tool using enzyme activities can display an infection prematurely. This means that an increased enzyme activity (especially MPO, NHE, LYS, gelatinase, pH) measured overed 3 days, would indicate a change in the wound bed (infection, Inflammation) earlier than the regularly performed clinical assessment. Part 2: The aim of this part of the study was to evaluate (I) the possibility of wound fluid acquisition by means of an "additional collector" during ongoing NPWT and to answer if (II) this secretion can be biochemically analyzed for enzyme activities in order to be able to detect a change in the wound situation at an early stage.

NCT ID: NCT02413879 Completed - Colorectal Surgery Clinical Trials

Cleancision IntRaoperative Contamination prEvention Study

CIRCE
Start date: March 2015
Phase: N/A
Study type: Interventional

This study entitled, An Evaluation of the Safety and Efficacy of the CleanCision Wound Retraction and Protection System in Protecting Surgical Incisions from Intraoperative Contamination When Used during Colorectal Surgery, is designed to evaluate contamination at the wound incision site when the CleanCision is used during surgery.

NCT ID: NCT02078830 Completed - Wound Contamination Clinical Trials

Prospective Randomised Study for Use of CHG Dressing at Entry Site of EVD's to Reduce EVD-associated Infections

EVDAI
Start date: October 2013
Phase: N/A
Study type: Interventional

The objective of this study is to assess the efficacy of 3M™ Tegaderm™ CHG I.V. Securement Dressing at the entry-site of a EVD in reducing quantity of microorganisms (CFU/cm2) after a time period of 5 days as a surrogate marker for EVD-associated infections [1, 2], compared to a nonantimicrobial polyurethane 3M Tegaderm™ Transparent Film Dressing. We aim to investigate, if the adjunct of an additional CHG-impregnated device on a routinely basis for the daily care is as a valuable and effective option to reduce contamination of the EVD entry-site and consecutive colonization of the catheter.